A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT05236621 · UNKNOWN
Trial details
- NCT number
- NCT05236621
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2022-06-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.